Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Nanoscale
|
July 7, 2020
Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature
Adam Leach, Peter Smyth, Laura Ferguson, et al.
Nature Communications
|
August 8, 2018
The identification of carbon dioxide mediated protein post-translational modifications
Victoria L Linthwaite, Joanna M Janus, Adrian P Brown, et al.
Journal of AOAC International
|
October 25, 2007
Analysis of flavonol aglycones and terpenelactones in Ginkgo biloba extract: A comparison of high-performance thin-layer chromatography and column high-performance liquid chromatography
Dean E Gray, Dale Messer, Andrew Porter, et al.
Nature Communications
|
October 5, 2018
Author Correction: The identification of carbon dioxide mediated protein post-translational modifications
Victoria L Linthwaite, Joanna M Janus, Adrian P Brown, et al.
Alzheimer'S Research & Therapy
|
October 2, 2024
High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer's disease
Mohammad Arastoo, Lewis K Penny, Richard Lofthouse, et al.
International Journal of Molecular Sciences
|
September 19, 2018
TOP2B: The First Thirty Years
Caroline A Austin, Ka C Lee, Rebecca L Swan, et al.
Free Radical Biology & Medicine
|
October 16, 2010
Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice
Biji T Kurien, Andrew Porter, Yaser Dorri, et al.
Biochemical Pharmacology
|
May 2, 2024
Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment
Olivier Govaere, Simon J Cockell, Michalina Zatorska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
Kub5-Hera <i></i> Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers
Edward A Motea, Farjana J Fattah, Ling Xiao, et al.
Nature Communications
|
May 31, 2018
STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap
Anna Woroniuk, Andrew Porter, Gavin White, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Nanoscale
|
July 7, 2020
Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature
Adam Leach, Peter Smyth, Laura Ferguson, et al.
Nature Communications
|
August 8, 2018
The identification of carbon dioxide mediated protein post-translational modifications
Victoria L Linthwaite, Joanna M Janus, Adrian P Brown, et al.
Journal of AOAC International
|
October 25, 2007
Analysis of flavonol aglycones and terpenelactones in Ginkgo biloba extract: A comparison of high-performance thin-layer chromatography and column high-performance liquid chromatography
Dean E Gray, Dale Messer, Andrew Porter, et al.
Nature Communications
|
October 5, 2018
Author Correction: The identification of carbon dioxide mediated protein post-translational modifications
Victoria L Linthwaite, Joanna M Janus, Adrian P Brown, et al.
Alzheimer'S Research & Therapy
|
October 2, 2024
High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer's disease
Mohammad Arastoo, Lewis K Penny, Richard Lofthouse, et al.
International Journal of Molecular Sciences
|
September 19, 2018
TOP2B: The First Thirty Years
Caroline A Austin, Ka C Lee, Rebecca L Swan, et al.
Free Radical Biology & Medicine
|
October 16, 2010
Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice
Biji T Kurien, Andrew Porter, Yaser Dorri, et al.
Biochemical Pharmacology
|
May 2, 2024
Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment
Olivier Govaere, Simon J Cockell, Michalina Zatorska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
Kub5-Hera <i></i> Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers
Edward A Motea, Farjana J Fattah, Ling Xiao, et al.
Nature Communications
|
May 31, 2018
STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap
Anna Woroniuk, Andrew Porter, Gavin White, et al.
Page
of 11